Dose Optimization using the Gene Therapy Virtual Twin® Platform Blog Post
This blog explains how using the Gene Therapy Virtual Twin® Platform can help optimize dosing for patients
This blog explains how using the Gene Therapy Virtual Twin® Platform can help optimize dosing for patients
Streamlines drug development by using PBPK modeling to predict drug behavior in virtual populations, optimize clinical study design, assess drug-drug interactions, and support regulatory decisions.
Certara’s Simcyp® Biologics platform enables scientists to model and predict the pharmacokinetics and pharmacodynamics of biologics, enhancing drug development and safety assessments.
This blog provides 8 clinical pharmacology and pharmacokinetic considerations that you should know for oligonucleotide therapeutics.
Expertly written patient narratives, enhanced by CoAuthor, ensuring consistency, quality, and improving safety reporting.
Narratives are an integral part of medical writing. Sponsors sometimes need to prepare large batches of these deliverables in a short period while most traditional methods prove unsuccessful in providing both consistency and quality. This can lead to questions...
Abstract During a pandemic caused by a novel pathogen (NP), drug repurposing offers the potential of a rapid treatment response via a repurposed drug (RD) while more targeted treatments are developed. Five steps of model‐informed drug repurposing (MIDR) are discussed:...
“You would not be able to tell 40 different writers were authoring these. It looked as though one person was writing them! The writers wrote a streamlined and visually-cohesive and consistent story that made reviewing the large set by only...
A global biotechnology company engineering precision genetic medicine for rare diseases was in need of expertise in early assessment of proposed clinical trial designs and their potential payer coverage. They engaged with Certara’s Cell & Gene Therapy practice because of...